Mallinckrodt plc News Headlines

MNK 
$88.82
*  
1.12
1.28%
Get MNK Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading MNK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog
9/18/2014 4:30:00 PM - Zacks.com

Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher - Tale of the Tape
9/18/2014 9:25:00 AM - Zacks.com

Novo Nordisk's Tresiba Effective in Children & Adolescents - Analyst Blog
9/17/2014 6:10:00 PM - Zacks.com

Time To Lighten Up On Big Tech As OECD Tax Man Cometh
9/17/2014 11:18:00 AM - Seeking Alpha

Dropping Oil Prices Made Me Drop Nabors In Favor Of Safety Growth Stock Mallinckrodt
9/17/2014 6:25:00 AM - Seeking Alpha

Nuvo Research: An Overlooked Stock With Great Upside Potential
9/16/2014 10:01:00 AM - Seeking Alpha

NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog
9/15/2014 7:05:00 PM - Zacks.com

MNK January 2017 Options Begin Trading
9/15/2014 1:10:30 PM - BNK Invest

Can Mallinckrodt public limited (MNK) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
9/12/2014 8:54:00 AM - Zacks.com

Mylan to Acquire U.S. Rights to Arixtra for up to $300M - Analyst Blog
9/11/2014 5:20:00 PM - Zacks.com

Actavis' Bystolic Combination Gets Negative FDA Panel Vote - Analyst Blog
9/10/2014 4:45:00 PM - Zacks.com

InsiderInsights.com Daily Round Up 9/9/14: Republic Services, Intevac, Bob Evans And Advanced Drainage Systems
9/10/2014 10:08:00 AM - Seeking Alpha

Endocyte (ECYT) Worth Watching: Stock Soars 17% - Tale of the Tape
9/10/2014 9:46:00 AM - Zacks.com

Actavis' Antibiotic under FDA Review, Response in 1Q15 - Analyst Blog
9/8/2014 5:20:00 PM - Zacks.com

Mallinckrodt (MNK) Shares March Higher, Can It Continue? - Tale of the Tape
9/8/2014 10:39:07 AM - Zacks.com

IntelliPharmaCeutics (IPCI) in Focus: Stock Gains 15.9% - Tale of the Tape
9/8/2014 9:25:00 AM - Zacks.com

Nuvo Research Settles Pennsaid Litigation With Mallinckrodt Pharma
9/8/2014 7:43:00 AM - RTT News

Mallinckrodt's Pain Therapy Hits Phase III Primary Endpoint - Analyst Blog
9/5/2014 5:05:00 PM - Zacks.com

Actavis' Gastrointestinal Drug Under FDA Priority Review - Analyst Blog
9/4/2014 4:30:00 PM - Zacks.com

Tetraphase Pharmaceuticals (TTPH) in Focus: Stock Gains 14.8% - Tale of the Tape
9/4/2014 9:46:00 AM - Zacks.com

10 Stocks Billionaire John Paulson Loves in 2014
9/4/2014 9:33:00 AM - TheStreet

Mallinckrodt Pharma's MNK-155 Shows Efficacy In Phase 3 Acute Pain Study
9/4/2014 9:07:00 AM - RTT News

Merck KGaA in Deal with S-TARget, Allergy Pipeline in Focus - Analyst Blog
9/3/2014 6:50:00 PM - Zacks.com

Novo Nordisk Drops Anti-Inflammatory R&D Activities - Analyst Blog
9/3/2014 6:20:00 PM - Zacks.com

RXi Pharmaceuticals (RXII) Jumps: Stock Moves 11.4% Higher - Tale of the Tape
9/3/2014 9:46:00 AM - Zacks.com